Ginkgo Bioworks Holdings Inc Class (DNA)
Deferred Revenue
$13.21M
Quarterly · Period ending: · USD
DNA Deferred Revenue
Latest reported$19.98Mperiod ending
Latest reported$19.98Mperiod ending
DNA FY Deferred Revenue ($0.00 → $19.98M)
Annual deferred revenue
High-resolution chart · PNG
DNA deferred revenue history
Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Deferred Revenue (USD) |
|---|---|
| 19,979,000 | |
| 30,599,000 | |
| 48,495,000 | |
| 47,817,000 | |
| 33,240,000 | |
| 0 | |
| 0 |